157 related articles for article (PubMed ID: 33017789)
1. N-substitution in isatin thiosemicarbazones decides nuclearity of Cu(II) complexes - Spectroscopic, molecular docking and cytotoxic studies.
Haribabu J; Alajrawy OI; Jeyalakshmi K; Balachandran C; Krishnan DA; Bhuvanesh N; Aoki S; Natarajan K; Karvembu R
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Feb; 246():118963. PubMed ID: 33017789
[TBL] [Abstract][Full Text] [Related]
2. Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(ii) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity.
Balakrishnan N; Haribabu J; Dhanabalan AK; Swaminathan S; Sun S; Dibwe DF; Bhuvanesh N; Awale S; Karvembu R
Dalton Trans; 2020 Jul; 49(27):9411-9424. PubMed ID: 32589180
[TBL] [Abstract][Full Text] [Related]
3. Halo-substituted thiosemicarbazones and their copper(II), nickel(II) complexes: detailed spectroscopic characterization and study of antitumour activity against HepG2 human hepatoblastoma cells.
Jagadeesh M; Kalangi SK; Sivarama Krishna L; Reddy AV
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():552-6. PubMed ID: 24084484
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and anticancer activity of chitosan functionalized isatin based thiosemicarbazones, and their copper(II) complexes.
Adhikari HS; Garai A; Yadav PN
Carbohydr Res; 2023 Apr; 526():108796. PubMed ID: 36944301
[TBL] [Abstract][Full Text] [Related]
5. Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation, DNA/albumin binding, biological profile analysis, and molecular docking study.
Biswas N; Saha S; Khanra S; Sarkar A; Prasad Mandal D; Bhattacharjee S; Chaudhuri A; Chakraborty S; Roy Choudhury C
J Biomol Struct Dyn; 2019 Jul; 37(11):2801-2822. PubMed ID: 30101692
[TBL] [Abstract][Full Text] [Related]
6. 8-Hydroxyquinoline derived p-halo N4-phenyl substituted thiosemicarbazones: Crystal structures, spectral characterization and in vitro cytotoxic studies of their Co(III), Ni(II) and Cu(II) complexes.
Kotian A; Kamat V; Naik K; Kokare DG; Kumara K; Neratur KL; Kumbar V; Bhat K; Revankar VK
Bioorg Chem; 2021 Jul; 112():104962. PubMed ID: 33992968
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic characterization, antioxidant and antitumour studies of novel bromo substituted thiosemicarbazone and its copper(II), nickel(II) and palladium(II) complexes.
Jagadeesh M; Lavanya M; Kalangi SK; Sarala Y; Ramachandraiah C; Varada Reddy A
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():180-4. PubMed ID: 25064500
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, theoretical, molecular docking and
Musthafa M; Konakanchi R; Ganguly R; Balachandran C; Aoki S; Sreekanth A
J Biomol Struct Dyn; 2021 Aug; 39(12):4346-4361. PubMed ID: 32597724
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures, spectroscopic properties of new cobalt(II), nickel(II), zinc(II) and palladium(II) complexes derived from 2-acetyl-5-chloro thiophene thiosemicarbazone: Anticancer evaluation.
Şen B; Kalhan HK; Demir V; Güler EE; Kayalı HA; Subaşı E
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():550-559. PubMed ID: 30813058
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Ni(II) complexes bearing indole-based thiosemicarbazone ligands for interaction with biomolecules and some biological applications.
Haribabu J; Jeyalakshmi K; Arun Y; Bhuvanesh NSP; Perumal PT; Karvembu R
J Biol Inorg Chem; 2017 Jun; 22(4):461-480. PubMed ID: 27995332
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility,
Bharathi S; Mahendiran D; Kumar RS; Kim YG; Gajendiran M; Kim K; Rahiman AK
Chem Res Toxicol; 2019 Aug; 32(8):1554-1571. PubMed ID: 31241919
[TBL] [Abstract][Full Text] [Related]
13. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
14. Chromophore appended DPA-based copper(II) complexes with a diimine motif towards DNA binding and fragmentation studies.
Mathur S; Karumban KS; Muley A; Tuti N; Shaji UP; Roy I; Verma A; Kumawat MK; Roy A; Maji S
Dalton Trans; 2024 Jan; 53(3):1163-1177. PubMed ID: 38105760
[TBL] [Abstract][Full Text] [Related]
15. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl-3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde.
Leovac VM; Bogdanović GA; Jovanović LS; Joksović L; Marković V; Joksović MD; Denčić SM; Isaković A; Marković I; Heinemann FW; Trifunović S; Đalović I
J Inorg Biochem; 2011 Nov; 105(11):1413-21. PubMed ID: 21955843
[TBL] [Abstract][Full Text] [Related]
17. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
18. RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies.
Parveen S; Fatima K; Zehra S; Arjmand F
J Biomol Struct Dyn; 2021 Oct; 39(16):6070-6083. PubMed ID: 32715942
[TBL] [Abstract][Full Text] [Related]
19. Copper(II) complexes based on thiosemicarbazone ligand: Preparation, crystal structure, Hirshfeld surface, energy framework, antiMycobacterium activity, in silico and molecular docking studies.
Souza RAC; Costa WRP; de F Faria E; Bessa MAS; Menezes RD; Martins CHG; Maia PIS; Deflon VM; Oliveira CG
J Inorg Biochem; 2021 Oct; 223():111543. PubMed ID: 34298306
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids.
Zhang CL; Liu YX; Zhang XM; Chen S; Shen F; Xiong YH; Liu W; Mao ZW; Le XY
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():414-425. PubMed ID: 30033272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
